Results from four AZD1222 (ChAdOx1 nCoV-19) vaccine trials for COVID-19
||AZD1222 (ChAdOx1 nCoV-19)|
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
|Plain Language Summary of the Lancet journal article focusing on results of 4 trials of the AZD1222 vaccine used to prevent COVID-19 disease caused by the SARS-CoV-2 virus|
Stay informed about new Trial Results Summaries with our email notification service
No locations posted.